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Abstract
Background: Diabetics have high prevalence of subclinical coronary artery disease (CAD) with typical
characteristics (diffuse disease, large calcifications). Although 64-slice multidetector computed tomography (MDCT)
coronary angiography has high diagnostic accuracy to detect CAD, its diagnostic performance in diabetics with
suspected CAD is unknown. To compare the diagnostic performance of 64-slice MDCT between diabetics and non-
diabetics with suspected CAD scheduled for invasive coronary angiography (ICA).
Methods: We enrolled one hundred and five diabetic patients (92 men, age 65 +/- 9 years, Group 1) and 105 non-
diabetic patients (63 men, age 63+/-5 years, Group 2) with indication to ICA for suspected CAD undergoing
coronary 64-slice MDCT before ICA.
Results: In Group 1, the overall feasibility of coronary artery visualization was 93.8%. The most frequent artifact was
blooming due to large coronary calcifications (54 artifacts, 67%). In Group 2, the overall feasibility was significantly
higher vs. Group 1 (97%, p < 0.0001). In Group 1, the segment-based analysis showed a MDCT sensibility,
specificity, positive predictive value, negative predictive value and accuracy for the detection of ≥50% luminal
narrowing of 77%, 90%, 70%, 93% and 87%, respectively. In Group 2, all these parameters were significantly higher
vs. Group 1. In the patient-based analysis, specificity, negative predictive value and accuracy were significantly
lower in Group 1 vs. Group 2.
Conclusions: Although MDCT has high sensitivity for early identification of significant CAD in diabetics, its
diagnostic performance is significantly reduced in these patients as compared to non-diabetics with similar clinical
characteristics.
Background
Glucose intolerance and diabetes mellitus (DM) are
associated with premature atherosclerosis [1] and
increased risk for coronary artery disease (CAD). More-
over, traditional cardiovascular risk factors such as
hypertension, dyslipidemia and obesity cluster in
patients with DM [2]. All these factors may explain why
diabetics have accelerated progression and, often, more
aggressive and diffuse development of coronary athero-
sclerosis in frequently smaller native vessels [3] and
experience higher morbidity and mortality. Moreover,
CAD diagnosis may be missed or delayed in these
patients since the typical symptoms are often masked
despite diffuse multi-vessel coronary atherosclerosis is
frequently present. Therefore, there is a clear clinical
need to detect CAD at an early stage in DM patients
who are at risk of both fatal and non fatal cardiac events
before the onset of symptoms.
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Sixty-four-slice multidetector computed tomography
(MDCT) coronary angiography is currently considered a
reliable diagnostic method for the evaluation of patients
with known or suspected CAD with high diagnostic per-
formance for the detection of significant coronary steno-
sis [4]. Moreover, several studies demonstrated its ability
to detect and differentiate calcified and noncalcified cor-
onary atherosclerotic plaques noninvasively [5]. Iwasaki
et al. demonstrated that the prevalence of subclinical
atherosclerosis in asymptomatic DM patients assessed
with 64-slice MDCT is higher than that observed in
asymptomatic non-diabetic patients. Indeed, coronary
plaques and significant coronary stenoses were found in
68% and 16% of non-diabetics as compared to 91% and
33% of diabetics [6]. However, only one study demon-
strated that MDCT may have a prognostic role in DM
patients, showing a significantly lower event-free survival
in them as compared to a control population and a
close correlation between the presence of significant
CAD at MDCT and CAD-related events [7]. Disappoint-
ingly, the diagnostic accuracy of MDCT in diabetics can
be influenced by two main problems: the increased pre-
test likelihood of CAD that affects lower diagnostic per-
formance of MDCT [8,9], and the coronary artery
lesions characteristically located in smaller vessels [10]
and more frequently presenting extensive calcifications
[3,6,11]. These are the main causes of unevaluability of
coronary arteries at MDCT [12]. As a result, the clinical
role of MDCT coronary angiography as a non-invasive
diagnostic tool in diabetics for detecting hemodynami-
cally relevant stenoses before they become clinically evi-
dent remains to be determined. Therefore, the aim of
this study was to compare the diagnostic performance
of 64-slice MDCT between DM patients and a control
population with suspected but unknown CAD scheduled
for invasive coronary angiography (ICA).
Methods
Study population
One hundred and sixteen consecutive diabetic patients
(Group 1) and 115 consecutive non-diabetic patients,
who were referred for ICA for suspected CAD because of
chest pain and/or inconclusive stress test, were enrolled
from January 2007 to December 2008 (Table 1). Patients
were classified as affected by DM if they carried an estab-
lished diagnosis of this ailment made by a physician and/
or were receiving treatment with insulin or oral hypogly-
cemic agents. Exclusion criteria were previous ICA, con-
traindication to the administration of iodine-based
contrast agents, pregnancy, history of known CAD,
impaired renal function (creatinine clearance <60 ml/
min), inability to sustain a 15-second breath hold and
cardiac arrhythmias. Based on these exclusion criteria, 21
patients were not enrolled in the study because of
inability to sustain the breath hold (3 in Group 1, 2 in
Group 2), cardiac arrhythmias (6 in Group 1, 5 in Group
2) and impaired renal function (2 in Group 1, 3 in Group
2). Thus, the analytic study population consisted of 210
subjects. All patients underwent MDCT within 3.1 ± 0.5
days prior to ICA. The study was approved by our insti-
tution’s scientific and ethical committees and all partici-
pating patients gave written informed consent. At
admission the pre-test likelihood of CAD was defined
using an estimated predicted probability according to
American Heart Association (AHA) guidelines for the
management of chronic stable angina, based on age, sex,
and symptoms [13].
Patient preparation for 64-slice MDCT coronary
angiography
All patients were connected to an electrocardiographic
monitor before the scan and the resting heart rate was
monitored continuously. Metoprolol was intravenously
administered before MDCT with a titration dose up to
20 mg in all patients with heart rate >65 bpm.
Scan protocol
Scanning was performed with a 64-slice MDCT scanner
(VCT, GE Medical System, Milwaukee, WI) with 64 ×
0.625 mm collimation, 330 msec gantry rotation time
and 120 Kv tube voltage. Dose modulation was obtained
with “electrocardiographic gating” for a maximum gan-
try delivery between 40% and 80% during the R-R inter-
val and least delivery during the remainder of the
cardiac cycle leading to an estimated mean radiation
exposure of 14.3 mSv. The “smart prep” scanning was
performed in order to obtain a four chamber projection.
A bolus of 80 ml of high concentration contrast med-
ium (Iomeron 400 mg/ml, Bracco, Milan, Italy) was
administered intravenously at 5 ml/sec, followed by
50 ml of saline injected at the same infusion rate. The
scan was initiated according to the bolus-tracking
technique.
MDCT image analysis
The coronary calcium score was assessed with a dedi-
cated software application (CaScore Package - GE
Healthcare, Milwaukee, WI) and the overall Agatston
score was recorded for each patient. Image data sets
were analyzed using volume rendering, multi-planar
reconstruction and vessel analysis software packages on
a post-processing workstation (Advantage Workstation
version 4.2, GE Healthcare, Milwaukee, WI). Images
were reconstructed with an effective slice width of 0.625
mm at an increment of 0.4 mm. The causes of impaired
image quality were classified as motion artifacts related
to the inability to sustain the breath hold, blooming
effect due to large calcifications of coronary vessels, slice
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misalignment related to heart rate variation or premature
ventricular beats during the scan, presence of cardiac
device and impaired signal/image noise ratio. Coronary
artery segments were classified according to the 15-
segment AHA classification [14]. All segments with a
diameter of at least 1.5 mm at their origin were included.
Two independent and blinded readers (D.A., G.P.) classi-
fied each vessel segment for the presence of significant
stenosis, defined as narrowing of the coronary lumen
exceeding 50%. For any disagreement in data analysis
between the two readers, consensus agreement was
achieved. The CAD burden was defined as the number of
coronary segments with significant lesions and of coron-
ary segments with any plaques. Coronary arteries size
was evaluated measuring the lumen diameter of origin of
each coronary artery segment having more than 1.5 mm
in diameter, twice with the fixed window width of 700
Hounsfield units (HU) and window level of 250 HU
(WW/WL), which are previously reported [15]. To mea-
sure the lumen diameters, the shortest distance between
the contrast-agent filled artery contours was evaluated
[16]. The time needed for post-processing analysis was
recorded.
Invasive coronary angiography
Conventional ICA was performed with standard techni-
que using 6 Fr catheters. The coronary arteries were
classified using the AHA classification [14]. The angio-
grams were analyzed using a quantitative coronary
angiography software (QantCor. QCA, Pie Medical Ima-
ging, Maastricht, the Netherlands) by two interventional
cardiologists blinded to MDCT data sets. The severity of
Table 1 Baseline Characteristics
Group 1 Diabetic Patients Group 2 Control group p
Number of patients, n 105 105 ns
Gender (male/female),n 92/13 92/13 ns
Age (years), mean ± SD 65.4 ± 9.4 63.3 ± 5.5 ns
BMI (Kg/m2), mean ± SD 28.3 ± 3.4 28. ± 5 4 ns
Serum creatinine (mg/dl), mean ± SD 1.12 ± 0.3 1.04 ± 0.2 ns
CLINICAL HISTORY
Angina, n (%) 54 (51%) 62 (59%) ns
Inconclusive stress test, n(%) 56 (53%) 62 (58%) ns
Valvular disease, n (%) 0 (0%) 2 (2%) ns
Arrhytmia, n (%) 0 (0%) 2 (2%) ns
DCM, n (%) 12 (8%) 10 (9.5%) ns
CARDIOVASCULAR RISK FACTORS
Diabetes mellitus, n (%) 105 (100%) 0 (0%) 0.01
Insulin dependent, n (%) 12 (11.5%) - -
Glycosylated haemoglobin (%) 7.1 ± 2.4% - -
Hypertension, n (%) 74 (70%) 63 (60%) ns
Hypercholesterolemia, n (%) 59 (56%) 45 (43%) ns
Current smoking, n (%) 31 (30%) 29 (28%) ns
Family history of CAD, n (%) 21 (20%) 27 (26%) ns
PRE-TEST LIKELIHOOD OF CAD 51% 52% ns
b-BLOCKER
Number of patients, n (%) 66 (63%) 63 (60%) ns
Dose (mg), mean ± SD 11.2 ± 5.3 11.4 ± 2.5 ns
HEART RATE (bpm), mean ± SD 61.2 ± 9.3 58 ± 4.6 ns
AGATSTON SCORE
mean ± SD 479 ± 492 356 ± 367 0.01
median (range) 346 (0-1740) 240 (0-1650) 0.01
CAD extension
0-vessel, n (%) 10 (11%) 18 (13%) ns
1-vessel, n (%) 28 (27%) 20 (19%) ns
2-vessel, n (%) 33 (30%) 34 (34%) ns
3-vessel, n (%) 34 (32%) 33 (34%) ns
BMI = Body mass Index; CAD = Coronary artery disease; DCM = Dilated cardiomiopathy;
DS = standard deviation.
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coronary stenoses was quantified in 2 orthogonal planes,
and a stenosis was classified as significant if the lumen
diameter reduction was >50%.
Statistical analysis
Statistical analysis was performed using the SPSS 13.0
software (SPSS Inc, Chicago, IL). Continuous variables
were expressed as mean ± SD, and discrete variables as
absolute numbers and percentages. The Student t-test
was used to test differences of continuous variables
between the two groups, and Chi-square test or
Fischer’s exact test were used on the basis of the events
observed to study differences regarding categorical data.
A p value < 0.05 was considered statistically significant.
Concerning coronary artery evaluation, the overall feasi-
bility (number of segments evaluable/total number of
coronary segments) of the MDCT scan was assessed. An
estimation of accuracy (sensitivity, specificity, positive
predictive value [PPV] and negative predictive value
[NPV]) was calculated on a segment-based model and
on a patient-based model, based on a 50% threshold
against the standard of ICA findings. On a patient-based
analysis, patients with at least 1 detected stenosis >50%
in a native coronary artery were classified as “positive”.
We also perform a segment-based analysis including all
segments for analysis with nonevaluable segments cen-
sored as “positive” [17]. The 95% confidence interval for
these parameters was calculated using the ratio estima-
tor for variance. The diagnostic performance between
the two groups was compared using the pairwise McNe-
mar’s test. The intra-observer and inter-observer varia-
bility for the detection of significant disease on MDCT
images were tested with a K test.
Results
Baseline characteristics
The two groups were homogeneous in terms of demo-
graphic and clinical characteristics with the exception of
the presence of DM in all patients of Group 1 (Table 1).
In this Group, 12 (11%) patients were insulin-dependent
individuals and 95 (89%) were using oral medications.
No significant difference was found in b-blockade pre-
treatment, heart rate during the scan, CAD extension at
ICA and clinical history between the two groups. On
the contrary, the calcium score was significantly higher
in Group 1 vs. Group 2 (Table 1).
MDCT feasibility
The time needed for post-processing analysis was signif-
icantly longer in Group 1 (35 ± 18 min) vs. Group 2
(21 ± 14 min, p < 0.01). The overall feasibility was sig-
nificantly better in Group 2 than in Group 1 (97% vs.
94%, p = 0.0001) due to a significantly lower number of
artifacts (39 vs. 81, p < 0.0001). A sub-analysis of the
artifacts showed a higher percentage of blooming
artifacts due to large calcifications in Group 1 vs. Group 2
(67% vs. 36%, p = 0.0001). In a patient-based model, no
significant difference between the two groups was found
in the rate of other artifacts (Table 2). Figure 1 shows
MDCT result in a diabetic patient and illustrates the two
main anatomical features impacting the diagnostic accu-
racy of this imaging modality: small vessel size and large
coronary calcifications.
CAD imaging with MDCT
No significant difference was found between the two
groups both in terms of number of patients without sig-
nificant stenoses (16 patients of Group 1 vs. 18 patients
of Group 2) and with at least one significant stenosis of
the coronary arteries (89 patients of Group 1 vs. 87
patients of Group 2). The extension of CAD was also
similar (1-vessel disease: 28 patients in Group 1 vs. 20
patients in Group 2; 2-vessel disease: 30 patients in
Group 1 vs. 31 patients in Group 2; 3-vessel disease: 31
patients in Group 1 vs. 36 patients in Group 2). On the
contrary, the CAD burden in terms of number of coron-
ary segments with significant lesions (3.1 ± 2.2 vs. 2.5 ±
1.7, p = 0.01) and of coronary segments with coronary
plaques (5.3 ± 2.8 in vs. 4 ± 2.4, p = 0.001) was signifi-
cantly higher in Group 1 than in Group 2.
Coronary size
As shown in Table 3, the lumen diameter of all coron-
ary segments was significantly lower in Group 1 vs.
Group 2, with the exception of 2 segments (proximal
left circumflex artery and middle left anterior descend-
ing artery).
MDCT accuracy in a segment-based model Group 1
The consensus between MDCT and ICA in classifying
the coronary stenoses as significant was achieved in 309
out of 1229 segments and as angiographically normal in
920 out of 1229 segments. Overall, 69 lesions were
underestimated by MDCT and 218 segments were
incorrectly graded as significantly stenotic. Sensitivity
was 76%, specificity 90% and overall accuracy 87%
(Table 4). The Kappa value for the detection of signifi-
cant coronary artery disease was 0.78 for intra-observer
agreement and 0.74 for inter-observer agreement.
Group 2
The presence of significant stenoses was correctly
detected in 251 segments and correctly excluded in 994
segments. Twenty-one significant lesions were missed by
MDCT and 37 stenoses rated as significant by MDCT
were not confirmed by ICA. Sensitivity was 92%, specifi-
city 96% and accuracy 96% (Table 5). The Kappa value
for detection of significant coronary artery disease was
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0.82 for intra-observer agreement and 0.78 for inter-
observer agreement.
Comparison of MDCT diagnostic accuracy in a segment-
based model
All the diagnostic parameters (sensitivity, specificity,
NPV, PPV and accuracy) were significantly (p = 0.001)
higher in Group 2 than in Group 1, either including
only the evaluable segments or all segments for analysis
with those nonevaluable censored as positive (Table 6).
Comparison of MDCT diagnostic accuracy in a patient-
based model
In Group 1, 87 out of 93 patients with significant ste-
noses in at least one coronary segment at ICA were cor-
rectly identified by MDCT (sensitivity 94%). Six patients
were missed by MDCT. Moreover, significant CAD was
correctly ruled out by MDCT in 3 patients, but in 9
cases a stenosis was diagnosed as significant by MDCT
and was found to be less than 50% at ICA (specificity of
33%). Specificity, NPV and accuracy were significantly
higher in Group 2 (83%, 79% and 93%, respectively)
than in Group 1 (33%, 25% and 86%, respectively)
(Table 6).
Discussion
The main findings of this study indicate that the non-
invasive detection of significant coronary artery stenoses
with 64-slice MDCT in DM patients as compared to
their non-diabetic counterparts with similar clinical
characteristics and suspicion of CAD requires a longer
time for post-processing analysis and has lower
Table 2 Comparison of feasibility and artifact rate in Group 1 and Group 2.
N° Feasibility n (%) Breath n (%) SM n (%) Ca n (%) S/N n (%) CD n (%)
GROUP 1 Segments 1310 1229 (94%) 11 (13%) 13 (16%) 54 (67%) 3 (4%) -
GROUP 2 Segments 1342 1303 (97%) 13 (33%) 10 (26%) 14 (36%) 2 (6%) -
P - 0.0001 NS NS 0.0001 NS -
Breath: artifacts due to breath/chest movement; SM: slice misalignment due to heart rate variability or premature beat during the scan; Ca: blooming artifact due
to large calcifications; S/N: impaired image signal/image noise ratio; CD: cardiac device.
Figure 1 MDCT volume rendering (upper panels 1A, 1B, 1C) and multiplanar reconstruction (lower panels 1D, 1E, 1F) showing the
small coronary size and large coronary calcifications of the epicardial coronary vessels. The white arrow indicate an occlusion of the
middle portion of LAD (1A, 1D). D1 = first diagonal branch; LAD = left anterior descending coronary artery; LCX = left circumflex artery; LM = left
main artery; MDCT = multidetector computed tomography; RCA = right coronary artery.
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feasibility and diagnostic accuracy. Indeed, the overall
feasibility of MDCT evaluation of the coronary tree was
significantly lower in the DM Group than in non-dia-
betic patients, due to a significantly higher number of
artifacts. In agreement with previous studies that
demonstrated a higher rate of extensive coronary artery
calcifications in diabetics [3,6,11], our feasibility
sub-analysis showed that blooming artifacts due to large
calcifications were significantly more frequent in Group 1
as compared to Group 2. A very recent study of Chu et al.
confirmed that calcified plaques are the most common
type of coronary plaque in diabetics [18]. Of note, no
Table 3 Comparison of the coronary artery lumen diameter between Group 1 and Group 2
Segments Lumen Diameter in Group 1 Lumen Diameter in Group 2 P values
LM (mean ± SD, mm) 4,0 ± 0,3 4,2 ± 0,4 0.0001
Proximal LAD (mean ± SD, mm) 3,5 ± 0,4 3,8 ± 0,2 0.0001
Mid LAD (mean ± SD, mm) 2,8 ± 0,1 2,8 ± 0,2 0.30
Distal LAD (mean ± SD, mm) 1,8 ± 0,2 2,3 ± 0,4 0.0001
D1 (mean ± SD, mm) 1,7 ± 0,3 2,6 ± 0,5 0.0001
D2 (mean ± SD, mm) 1,6 ± 0,1 2,5 ± 0,5 0.0001
Proximal LCX (mean ± SD, mm) 3,0 ± 0,1 3,0 ± 0,4 0.56
Mid LCX (mean ± SD, mm) 2,5 ± 0,3 2,8 ± 0,5 0.008
Distal LCX (mean ± SD, mm) 2,4 ± 0,2 2,3 ± 0,5 0.001
M1 (mean ± SD, mm) 2,5 ± 0,4 2,7 ± 0,5 0.0001
M2 (mean ± SD, mm) 1,8 ± 0,5 2,4 ± 0,4 0.0001
Proximal RCA (mean ± SD, mm) 3,0 ± 0,2 3,9 ± 0,5 0.0001
Distal RCA (mean ± SD, mm) 2,8 ± 0,2 3,4 ± 0,5 0.0001
PLA (mean ± SD, mm) 2,5 ± 0,2 2,8 ± 0,4 0.0001
PDA (mean ± SD, mm) 2,6 ± 0,2 3,0 ± 0,4 0.0001
D1 = First diagonal branch; D2 = Second diagonal branch; LM = left main;
LAD = left anterior descending; LCX = left circumflex; M1 = First marginal branch;
M2 = Second marginal branch; PLA = Postero-lateral artery;
PDA = Posterior descending artery.
Table 4 Diagnostic accuracy of MDCT for the detection of significant (>50%) coronary stenosis using a segment-based
model in Group 1 (Segments for analysis only).
Segments N TN TP FN FP Se Sp NPV PPV Accuracy
LM 99 85 1 7 6 13% 93% 92% 14% 87%
Proximal LAD 99 44 43 0 12 100% 79% 100% 78% 88%
Mid LAD 93 40 38 7 8 84% 83% 85% 83% 84%
Distal LAD 98 86 6 4 2 60% 98% 96% 75% 94%
D1 80 48 15 6 11 71% 81% 89% 58% 79%
D2 58 52 1 1 4 50% 93% 98% 20% 91%
Proximal LCX 101 65 22 3 11 88% 86% 96% 67% 86%
Mid LCX 95 70 16 4 5 80% 93% 95% 76% 91%
Distal LCX 92 84 3 2 3 60% 97% 98% 50% 95%
M1 76 54 8 7 7 53% 89% 89% 53% 82%
M2 17 14 2 1 0 67% 100% 93% 100% 94%
Proximal RCA 91 47 25 11 8 69% 85% 81% 76% 79%
Distal RCA 89 44 28 8 9 83% 78% 85% 76% 83%
PLA 64 52 6 2 4 75% 93% 96% 60% 91%
PDA 77 66 2 7 2 22% 97% 90% 50% 88%
All segments 1229 851 218 69 91 76% (72-82) 90% (88-92) 93% (91-94) 71% (65-73) 87% (86-90)
D1 = First diagonal branch; D2 = Second diagonal branch; FN = false negative; FP = false positive;
LM = left main; LAD = left anterior descending; LCX = left circumflex; M1 = First marginal branch;
M2 = Second marginal branch; NPV = negative predictive value; PLA = Postero-lateral artery;
PDA = Posterior descending artery; PPV = positive predictive value; Se = Sensitivity;
Sp = Specificity; TN = true negative; TP = true positive;
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difference was found in the present study between the two
Groups in the rate of other artifacts that can affect MDCT
accuracy. This was likely due to similar demographic and
clinical characteristics and heart rate during the scan in
the two Groups.
Our study shows that the diagnostic performance
of MDCT in DM patients with suspected CAD is
significantly lower compared to non-diabetic patients
with similar clinical characteristics and also lower than
that reported by previous studies that included patients
without DM [4]. Indeed, in our DM population, 69
lesions were underestimated by MDCT and 218 seg-
ments were incorrectly graded as significantly stenotic.
In a segment-based model, the overall sensitivity was
Table 5 Diagnostic accuracy of MDCT for the detection of significant (>50%) coronary stenosis using a segment-based
model in Group 2 (Segments for analysis only).
Segments N TN TP FN FP Se Sp NPV PPV Accuracy
LM 104 99 4 1 0 80% 100% 99% 100% 99%
Proximal LAD 94 46 45 1 2 98% 96% 98% 96% 97%
Mid LAD 91 44 42 1 4 98% 92% 98% 91% 94%
Distal LAD 99 86 10 2 1 83% 99% 98% 91% 97%
D1 86 66 19 0 1 100% 98% 100% 95% 99%
D2 30 27 3 0 0 100% 100% 100% 100% 100%
Proximal LCX 96 70 17 3 6 85% 92% 96% 74% 91%
Mid LCX 94 72 18 2 2 90% 97% 97% 90% 96%
Distal LCX 101 89 8 2 2 80% 98% 98% 80% 96%
M1 89 72 9 2 6 82% 92% 97% 60% 91%
M2 24 19 2 0 3 100% 86% 100% 40% 88%
Proximal RCA 99 66 28 0 5 100% 93% 100% 85% 95%
Distal RCA 96 66 25 3 2 89% 97% 96% 93% 95%
PLA 100 85 12 1 2 92% 98% 99% 86% 97%
PDA 100 87 9 3 1 75% 99% 97% 90% 96%
All segments 1303 994 251 21 37 92% (87-94) 96% (94-97) 98% (96-99) 87% (86-89) 96% (93-97)
D1 = First diagonal branch; D2 = Second diagonal branch; FN = false negative; FP = false positive;
LM = left main; LAD = Left anterior descending; LCX = left circumflex; M1 = First marginal branch;
M2 = Second marginal branch; NPV = Negative predictive value; PLA = Postero-lateral artery;
PDA = Posterior descending artery; PPV = Positive predictive value; Se = Sensitivity;
Sp = Specificity; TN = True negative; TP = True positive;
Table 6 Comparison of the diagnostic accuracy of MDCT for the detection of significant (>50%) coronary stenosis
between Group 1 and Group 2.
SEGMENT-BASED MODEL - SEGMENTS FOR ANALYSIS ONLY
Group N° TN TP FN FP Se Sp NPV PPV Accuracy
Group 1 1229 851 218 69 91 76% (72-82) 90% (88-92) 93% (91-94) 71% (65-73) 87% (86-89)
Group 2 1303 994 251 21 37 92% (87-94) 96% (94-97) 98% (96-99) 87% (86-89) 96% (93-97)
P - - - - - 0.001 0.001 0.001 0.001 0.001
SEGMENT-BASED MODEL - ALL SEGMENTS FOR ANALYSIS WITH NON EVALUABLE SEGMENTS “POSITIVE”
Group N TN TP FN FP Se Sp NPV PPV Accuracy
Group 1 1310 851 243 69 147 78% (73-82) 85% (83-87) 92% (91-94) 62% (57-65) 83% (81-85)
Group 2 1342 994 251 21 76 92% (89-95) 93% (91-94) 98% (97-99) 77% (81-92) 93% (91-94)
P - - - - - 0.001 0.001 0.001 0.001 0.001
PATIENT-BASED MODEL - SEGMENTS FOR ANALYSIS ONLY
Group N° TN TP FN FP Se Sp NPV PPV Accuracy
Group 1 105 3 87 6 9 94% (89-99) 33% (0-51) 25% (0-90) 91% (85-100) 86% (82-88)
Group 2 105 15 83 4 3 95% (91-100) 83% (66-100) 79% (61-97) 97% (93-100) 93% (89-98)
P - - - - - NS 0.01 0.001 NS 0.05
FN = False negative; FP = False positive; NPV = negative predictive value; PPV = positive
predictive value; Se = Sensitivity; Sp = Specificity; TN = true negative; TP = true positive.
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76%, with a value of only 13% for the left main coronary
artery, while specificity and accuracy were 90% and 87%,
respectively. Thus, all parameters were significantly lower
in the DM Group than those found in the non-diabetic
Group because the former had a lower prevalence of false
negative (21 segments) and showed mainly false positive
(37 segments). Similarly, in a patient-based model the
diagnostic performance of MDCT in the DM Group was
less than satisfactory, mainly because 9 patients were diag-
nosed with MDCT as affected by significant CAD that was
not confirmed by ICA. This explains the significantly
lower specificity, NPV and accuracy found in DM patients
as compared to their non-diabetic counterparts. The
worse diagnostic accuracy found in DM patients is likely
due to several factors. First, DM is associated with more
prevalent and extensive coronary calcifications that
impede the correct visualization of the coronary lumen.
Indeed, accumulation of calcium in the arterial wall of
patients affected by DM is not limited to the subintimal
space, but often extends in the medial layer [5]. A very
recent study of Maffei et al. confirmed that coronary pla-
que burden and coronary calcium score are higher in dia-
betic vs. non-diabetic patients [19]. The calcium burden
affects not only MDCT feasibility but also the quantifica-
tion of the coronary stenosis, sometimes leading to an
overestimation of the lesion severity [20]. Second, com-
pared to non-diabetic individuals, DM patients have a
more extensive plaque burden, as shown in several pre-
vious studies [6,21] and confirmed by our results, which
has a strong influence on MDCT diagnostic accuracy [22].
Third, the small coronary size and lumen area, typical of
DM patients [10,23] and confirmed in our study, cause dif-
ficulties detecting focal lesions and differentiating between
significant and non-significant stenoses, since the small
coronary lumen dimension is proximal to the imaging
technique resolution.
Finally, it is noteworthy that the large CAD burden
and the difficulty to correctly evaluate a coronary artery
with massive wall calcifications and small lumen dia-
meter increased significantly the time needed for post-
processing analysis of the MDCT images in diabetic
compared to non-diabetic patients. These shortcomings
underscore the need to develop further refinement of
MDCT technology to overcome the problems related to
the CAD features of DM.
Clinical Implications
Our study demonstrates that in a high-risk population
with unknown CAD, as in the case of our DM patients,
MDCT often find severe coronary atherosclerosis, both
in terms of the number of patients with significant multi-
vessel disease and atherosclerotic burden. This finding is
in agreement with those of previous studies with 64-slice
MDCT that indicated a higher prevalence of any type of
coronary plaques and of significant coronary stenoses
and a larger plaque burden in asymptomatic diabetics
compared to non-diabetic patients [6,21]. These results
support the concept that MDCT coronary angiography is
an excellent noninvasive technique for early identification
of significant CAD in high-risk patients with inconclusive
or unfeasible noninvasive stress test results [24]. Thus, it
may represent a valuable tool for early detection of CAD
to risk-stratify DM patients with the aim of differentiat-
ing those who are in need of coronary revascularization
from those who may benefit from aggressive medical
management. In this regard, despite the lower overall
diagnostic accuracy in the DM population, 87 out of 93
patients with a significant stenosis in at least one coron-
ary segment at ICA were correctly identified by MDCT.
According to the patient-based model, this translated in
a sensitivity of 94%. On the hand, the number of DM
patients in whom CAD severity was overestimated is one
of the clear limitations of MDCT that was underlined by
this study. Indeed, significant CAD was correctly ruled
out by MDCT in 3 patients, but in 9 cases a stenosis was
diagnosed as significant by MDCT and was found to be
less than 50% at ICA, translating in a specificity of only
33%. This low specificity in diabetics should be taken in
account when interpreting MDCT results because may
lead the physician to subject several patients to an ICA
that is not clinically needed for them because CAD is dif-
fuse but subcritical. Recently, a high-definition MDCT
scanner with improved in-plane spatial resolution (230
μm) and the ability to reconstruct images using a novel
applied statistical iterative reconstruction algorithm has
been introduced in the clinical practice [25]. It’s concei-
vable that the higher spatial resolution would be particu-
larly useful for the assessment of coronary vessels with
large calcifications as in the case of DM patients.
Study limitations
We describe the results of a single-center study and
the number of enrolled patients was relatively small.
To date, however, this study represents the largest
cohort of DM patients in whom diagnostic accuracy of
MDCT was compared to non-diabetics subjects. More-
over, the two groups were well matched in terms of
demographic characteristics and coronary risk factors
other than DM.
Conclusions
Although MDCT has high sensitivity for early identifica-
tion of significant CAD in diabetics, its diagnostic
performance is significantly reduced in these patients
as compared to non-diabetics with similar clinical
characteristics.
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